Report

Craneware Group | 1HFY25 update – double digit growth

Craneware has released a positive update on its 1HFY25 results to the end of December, ahead of their publication which is expected to be on 11 March 2025. Management note another period of positive trading with double-digit growth of c10% in revenue to over US$100m and a similar increase in adjusted EBITDA to US$30.3m. The pace of growth in Annual Recurring Revenue (ARR) has increased to 3% and Net Revenue Retention was above 100%. Sales included the first major customer contract secured via the Microsoft Azure Marketplace, following the alliance Craneware announced last July. The group ended the period with net cash of US$40.6m (US$0.8m of net debt at 30 June 2024). The group is trading in line with market expectations and we maintain our current forecast including growth in EPS of 14%. Our discounted cash flow-based valuation of 3,073p is nearly 50% above the current share price.
Underlying
Craneware

Craneware is engaged in the development, licensing and ongoing support of computer software for the U.S. healthcare industry. Co.'s solutions span four product families: Patient Engagement, Charge Capture & Pricing, Revenue Collection & Retention, and Cost Analytics. The patient engagement segment provides: medical necessity & prior authorization, and patient responsibility. The charge capture & pricing segment provides procedures, pharmacy, and supplies. The revenue recovery & retention segment provides billing & claims analysis, audit management, and denials management. The cost analytics segment provides cost of care.

Provider
Capital Access Group
Capital Access Group

Capital Access Group advises companies on effective engagement with investors. Our experienced team offers market-leading access with hard-to-reach investors, including smaller institutions, pension funds and private client fund managers. These under-serviced investors are located not only in London but across the regions of the UK and Europe. We have an unrivalled knowledge of this extensive audience, to whom our published research is distributed, as well as to larger institutions. We offer this service as part of an integrated investor communications strategy to promote a company’s investment story.

Our clients, ranging from AIM to FTSE 100 companies, benefit from our professional, long-term relationships with investors. Not only do we identify and target investors, we contact them directly and relay their views back to clients with analysis, interpretation and advice. This ensures that our clients are in control of their investor engagement. The objective is to improve the reach and engagement with investors, which in turn strengthens the share price.

Analysts
Colin Smith

Other Reports on these Companies
Other Reports from Capital Access Group

ResearchPool Subscriptions

Get the most out of your insights

Get in touch